NZ273815A - Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides - Google Patents

Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides

Info

Publication number
NZ273815A
NZ273815A NZ273815A NZ27381594A NZ273815A NZ 273815 A NZ273815 A NZ 273815A NZ 273815 A NZ273815 A NZ 273815A NZ 27381594 A NZ27381594 A NZ 27381594A NZ 273815 A NZ273815 A NZ 273815A
Authority
NZ
New Zealand
Prior art keywords
isolated
autoimmune diseases
peptide compositions
diseases containing
purified peptides
Prior art date
Application number
NZ273815A
Other languages
English (en)
Inventor
Malcolm L Gefter
Ze Ev Shaked
Malcolm Morville
Original Assignee
Immulogic Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharma Corp filed Critical Immulogic Pharma Corp
Priority to NZ273815A priority Critical patent/NZ273815A/xx
Publication of NZ273815A publication Critical patent/NZ273815A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NZ273815A 1994-09-02 1994-09-02 Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides NZ273815A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ273815A NZ273815A (en) 1994-09-02 1994-09-02 Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ273815A NZ273815A (en) 1994-09-02 1994-09-02 Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides
PCT/US1994/010262 WO1996007428A1 (en) 1994-09-02 1994-09-02 Peptide compositions capable of down regulating an antigen specific immune response

Publications (1)

Publication Number Publication Date
NZ273815A true NZ273815A (en) 1999-05-28

Family

ID=22242963

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ273815A NZ273815A (en) 1994-09-02 1994-09-02 Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides

Country Status (6)

Country Link
EP (1) EP0783322A1 (xx)
JP (1) JPH10505356A (xx)
AU (1) AU7726094A (xx)
CZ (1) CZ63297A3 (xx)
NZ (1) NZ273815A (xx)
WO (1) WO1996007428A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2314515T3 (es) 1996-03-21 2009-03-16 Circassia Limited Peptidos cripticos y metodo para su identificacion.
DE10359352A1 (de) 2003-12-16 2005-07-21 Merck Patent Gmbh DNA-Sequenz und rekombinante Herstellung des Graspollen-Allergens Lol p 4
US7767212B2 (en) 2005-03-18 2010-08-03 Cytos Biotechnology Ag CAT allergen conjugates and uses thereof
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
GB0821806D0 (en) 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
CN102438643B (zh) 2008-11-30 2015-07-01 免疫桑特公司 用于治疗乳糜泻的组合物和方法
US10449228B2 (en) 2013-09-10 2019-10-22 Immusant, Inc. Dosage of a gluten peptide composition
WO2016054038A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU685392B2 (en) * 1992-04-09 1998-01-22 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from (ambrosia artemisiifolia)
NZ258701A (en) * 1992-11-12 1996-11-26 Immulogic Pharma Corp Allergenic cry j ii proteins and coding sequences from japanese cedar pollen, their production and therapeutic use
EP0688338A1 (en) * 1993-03-12 1995-12-27 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
CA2164326A1 (en) * 1993-06-02 1994-12-08 Wayne Robert Thomas Cryptic peptides for use in inducing immunologic tolerance
NZ271818A (en) * 1993-08-13 1997-11-24 Immulogic Pharma Corp T cell epitopes of ryegrass pollen antigen

Also Published As

Publication number Publication date
WO1996007428A1 (en) 1996-03-14
CZ63297A3 (en) 1997-08-13
JPH10505356A (ja) 1998-05-26
EP0783322A1 (en) 1997-07-16
AU7726094A (en) 1996-03-27

Similar Documents

Publication Publication Date Title
EP0785276A4 (en) MODIFICATION OF A PEPTIDE AND A PROTEIN
HK1003503A1 (en) Aerosol formulations of peptides and proteins
HUP9901186A3 (en) Pharmaceutical composition for immunomodulation based on peptides and adjuvants
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
HRP950612B1 (en) PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
AU1159897A (en) Analogs of peptide yy and uses thereof
NZ273815A (en) Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides
EP0820295A4 (en) MODIFIED ARGININE OR LYSINE CONTAINING PROTEINS AND PEPTIDES
DE69326255D1 (de) Elam-1 bindende peptide und zusammensetzungen
GB9614033D0 (en) Modified protein G and fragments thereof
IL116973A0 (en) Extraction of recombinant proteins
HUP9900089A3 (en) Peptide derivatives of dolastatin 15
EP0821694A4 (en) CONOTOXIN PEPTIDES
HUP9801680A3 (en) Peptides and remedy for autoimmune diseases comprising the same
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides
HU9401824D0 (en) Soybean protein or hydrolylates in pharmaceutical compositions to protect bioaltive peptides from enlymatic nactivation
GB9918843D0 (en) Anti-hiv peptides and proteins
IL127080A0 (en) The use of peptides derived from zona pelucida proteins for contraception and pharmaceutical compositions containing the same
HK1024006A1 (en) Peptide as diagnostic and therapeutic agent for autoimmune diseases
DE69420044D1 (de) Blutregulierende peptide
IL112094A0 (en) Novel peptides and pharmaceutical compositions comprising them
IL109902A0 (en) Enhanced expression of peptide molecules
BR9507063A (pt) Peptídeo derivado de substituição de peptídeo e composição farmacêuticas
IL116976A0 (en) Synthetic peptides and pharmaceutical compositions comprising them
AU3818095A (en) Separation of amino acids and peptides from protein hydrolysates

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: MERCK PATENT GMBH, DE

Free format text: OLD OWNER(S): HESKA CORPORATION

Owner name: MERCK PATENT GMBH, DE

Free format text: OLD OWNER(S): MERCK PATENT GMBH

EXPY Patent expired